We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04260217
Brief Title: APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia (MAPLE-1)

First Submitted : February 5, 2020
First Submitted that Met QC Criteria : February 5, 2020
First Posted : February 7, 2020

Last Update Submitted that Met QC Criteria : August 12, 2022
Last Update Posted : August 16, 2022